Senn, J.-D.; Fischli, S.; Slahor, L.; Schelbert, S.; Henzen, C.
Long-Term Effects of Initiating Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring (CGM) in People with Type 1 Diabetes and Unsatisfactory Diabetes Control. J. Clin. Med. 2019, 8, 394.
https://doi.org/10.3390/jcm8030394
AMA Style
Senn J-D, Fischli S, Slahor L, Schelbert S, Henzen C.
Long-Term Effects of Initiating Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring (CGM) in People with Type 1 Diabetes and Unsatisfactory Diabetes Control. Journal of Clinical Medicine. 2019; 8(3):394.
https://doi.org/10.3390/jcm8030394
Chicago/Turabian Style
Senn, Jon-Duri, Stefan Fischli, Lea Slahor, Susanne Schelbert, and Christoph Henzen.
2019. "Long-Term Effects of Initiating Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring (CGM) in People with Type 1 Diabetes and Unsatisfactory Diabetes Control" Journal of Clinical Medicine 8, no. 3: 394.
https://doi.org/10.3390/jcm8030394
APA Style
Senn, J. -D., Fischli, S., Slahor, L., Schelbert, S., & Henzen, C.
(2019). Long-Term Effects of Initiating Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring (CGM) in People with Type 1 Diabetes and Unsatisfactory Diabetes Control. Journal of Clinical Medicine, 8(3), 394.
https://doi.org/10.3390/jcm8030394